JDRF Applauds the Government of British Columbia for extending coverage of the insulin pump program to British Columbians living with type 1 diabetes
TORONTO (March 5, 2014) – JDRF applauds the Government of British Columbia for extending coverage of the insulin pump program for eligible British Columbians aged 19 to 25 years old. Currently, British Columbia covers the costs of insulin pumps to anyone 18 years and younger who are living with type 1 diabetes (T1D).
T1D is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone that enables people to get energy from food. Its onset has nothing to do with diet or lifestyle.
Affecting over 300,000 Canadians, T1D can occur at any age, leaving children and adults dependent on injected or pumped insulin for life. The number of people living with T1D is increasing by three to five per cent annually - the greatest rise being in children aged five to nine years. In British Columbia, it is estimated that over 19,000 individuals are living with T1D.
Insulin pump technology provides precise insulin delivery continuously day and night, helping individuals maintain glucose levels between meals, during exercise and overnight. Studies have shown that people living with T1D who use insulin pump therapy experience fewer complications and live longer, healthier lives. In fact, a better managed blood glucose regimen has been proven to reduce the number of heart, kidney and eye-related diabetes complications. By investing in insulin pump therapy in the short-term, we can take steps to lessen or prevent complications from developing later in life, which can result in savings for health care systems in the long-term.
JDRF British Columbia has been actively working on securing insulin pump coverage for all British Columbians with the goal to bring British Columbia’s support system in-line with coverage offered by most other provinces and territories in Canada, ensuring that individuals living with T1D in British Columbia have every opportunity to minimize the long-term complications of this chronic disease.
“We commend the Government of British Columbia for recognizing the importance of the insulin pump program by extending coverage to include young adults aged 19 to 25 years old,” said Dave Prowten, President and CEO, JDRF Canada. “The extended coverage is an important step in ensuring that all provinces across Canada will one day offer access to an insulin pump program to all Canadian children, adolescents and adults living with T1D.”
JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D. As the largest charitable supporter of T1D research, JDRF is currently sponsoring $530 million in scientific research in 17 countries.
For more information, please visit jdrf.ca.
For More Information:
Regional Manager, British Columbia and Yukon Region
640.320.1937 ext. 23